During the past decade, Gazi Universitesi Tip Fakultesi Hastanesi conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gazi Universitesi Tip Fakultesi Hastanesi" are "Chemotherapy-induced Thrombocytopenia" (1 trials), "Follicular Lymphoma" (1 trials), "Isocitrate Dehydrogenase" (1 trials), "Leukemia, Myeloid" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Gazi Universitesi Tip Fakultesi Hastanesi" in a lesser frequency.

Most popular intervention types in "Gazi Universitesi Tip Fakultesi Hastanesi" are "Drug" (5 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "AG-221" (1 trials), "Azacitidine" (1 trials), "BSC" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gazi Universitesi Tip Fakultesi Hastanesi" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Gazi Universitesi Tip Fakultesi Hastanesi". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Gazi Universitesi Tip Fakultesi Hastanesi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gazi Universitesi Tip Fakultesi Hastanesi, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".